IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q1 2021 Holdings

Filed 2021-05-14 | 21 holdings | $94.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cullinan Oncology Inc(CGEM)COM230031106$91.8M2,202,40797.4%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$2.1M679,1322.2%
Pliant Therapeutics Inc(PLRX)COM729139105$91.4K2,324,7950.1%
Repare Therapeutics Inc(RPTX)COM760273102$78.6K2,560,7030.1%
Prometheus Biosciences IncCOM74349U108$52.5K2,874,0320.1%
Orchard Therapeutics PLCADS68570P101$29.4K4,051,9720.0%
Oncorus IncCOM68236R103$24.7K1,771,7860.0%
Keros Therapeutics Inc(KROS)COM492327101$24.6K400,4680.0%
Ikena Oncology IncCOM45175G108$23.0K814,7560.0%
Larimar Therapeutics Inc(LRMR)COM517125100$22.1K1,515,1480.0%
Inozyme Pharma IncCOM45790W108$18.4K927,2640.0%
Freeline Therapeutics HldgsSPONSORED ADS35655L107$17.0K1,384,7430.0%
Akouos IncCOM00973J101$11.9K858,0270.0%
Precision Biosciences IncCOM74019P108$7.2K691,6290.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$1.2K50,0000.0%
Kezar Life Sciences IncCOM49372L100$1.0K174,1690.0%
Ovid Therapeutics Inc(OVID)COM690469101$995247,5100.0%
Global Blood Therapeutics inCOM37890U108$61115,0000.0%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$39640,2090.0%
Blueprint Medicines Corp(2L9)COM09627Y109$3403,5000.0%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$2282,0000.0%